ICE GROUP acquires ABC Farmaceutici S.p.A.

ABC is a pharmaceutical company based in Ivrea, Italy. Founded in 1925, the company is dedicated to the research, development, production and sale of pharmaceutical products and active ingredients.  Almost 100 years of activity and commitment to its patients have allowed ABC to obtain international patents in gastroenterology and pulmonology medical specialisations, as well as important global partnerships for the contract manufacture of several pharmaceutical formulations.

This transaction combines ABC with the ICE Group, which is one of the main producers of UDCA active pharmaceutical ingredient (API) and other specialty ingredients, largely focused on the development and manufacture of bile acid derivatives.

The highly complementary combination of ICE Group and ABC will drive strategic commercial and industrial synergies, consistent with the aim of providing added value to our customers through a vertically integrated value chain for UDCA finished dosage form (FDF) production, best in class quality, regulatory support and excellent supply chain reliability.

Mr Agostino Barazza, Chief Executive Officer of ICE Group, said: “This acquisition represents a very attractive opportunity to create the first fully vertically integrated global UDCA player & specialty API manufacturer, combining ICE’s well established international bile collection and API production network with ABC’s proven capabilities as a contract manufacturing organisation (CMO) for FDF”.

The combined entity will enjoy substantial growth potential due to its ability to offer new products and services to existing and new customers.

Mr Alberto Giraudi, the previous shareholder of ABC, will continue to play a role in the combined group as a minority shareholder and member of the board of directors of ICE S.p.A. Mr. Giraudi said: “ABC joins a large family with a global footprint, vertical integration and strong growth prospects unlocking new opportunities for the company and its employees. ABC will also become substantially more resilient and competitive for its UDCA CMO activities by joining one of the main UDCA API global players”.

A message from the Editor:

Thank you for reading this story on our news site - please take a moment to read this important message:

As you know, our aim is to bring you, the reader, an editorially led news site but journalism costs money and we rely on advertising and digital revenues to help to support them.

With the Covid-19 lockdown having a major impact on our industry as a whole, the advertising revenues we normally receive, which helps us cover the cost of our journalists and this website, have been drastically affected.

As such we need your help. If you can support our news sites with a small donation of even £1, your generosity will help us weather the storm and continue in our quest to deliver quality journalism.

In the meantime may I wish you the very best.

- Advertisement -

Related news